Search companies or stocks...
PMCBPharmaCyte Biotech, Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United…
Current stock price of PharmaCyte Biotech, Inc. (PMCB) stock is $0.480. The stock price is -1.52% lower in the session. The intraday range can be seen from this page. Volume of PharmaCyte Biotech, Inc. (PMCB) stock is 48.26K.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of PharmaCyte Biotech, Inc. (PMCB) can change with earnings, company news, and overall market sentiment. PharmaCyte Biotech, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether PharmaCyte Biotech, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PMCB on this page is 0.33. EPS on this page is 1.45. Compare those figures with peers and growth expectations before deciding if the current PharmaCyte Biotech, Inc. price is justified.
Historical performance for PharmaCyte Biotech, Inc. (PMCB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PMCB reacted to past earnings and market events.
Buying PharmaCyte Biotech, Inc. (PMCB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
